199 related articles for article (PubMed ID: 30081800)
1. [Relationship between levels of sex hormones and response to cardiac resynchronisation therapy in men].
Enina TN; Kuznetsov VA; Soldatova AM; Petelina TI; Krinochkin DV; Dyachkov SM; Rychkov AY; Gorbunova TY
Kardiologiia; 2018 SJul; 58(S7):24-35. PubMed ID: 30081800
[TBL] [Abstract][Full Text] [Related]
2. Echocardiography-based qualification and response assessment to cardiac resynchronisation therapy in patients with chronic heart failure. The matrix metalloproteinase-9 substudy.
Szulik M; Stabryła-Deska J; Boidol J; Lenarczyk R; Kalarus Z; Kukulski T
Kardiol Pol; 2011; 69(10):1043-51. PubMed ID: 22006606
[TBL] [Abstract][Full Text] [Related]
3. Cardiac resynchronization therapy in patients with chronic heart failure is associated with anti-inflammatory and anti-remodeling effects.
Stanciu AE; Vatasescu RG; Stanciu MM; Iorgulescu C; Vasile AI; Dorobantu M
Clin Biochem; 2013 Feb; 46(3):230-4. PubMed ID: 23159290
[TBL] [Abstract][Full Text] [Related]
4. Gender in cardiac resynchronisation therapy.
Enina TN; Kuznetsov VA; Soldatova AM; Petelina TI; Krinochkin DV; Rychkov AY; Nochrina OY
J Cardiovasc Thorac Res; 2018; 10(4):197-202. PubMed ID: 30680077
[No Abstract] [Full Text] [Related]
5. [Not Available].
Skvortsov AA; Narusov OY; Muksinova MD; Protasov VN; Protasova DE; Kuznetsova TV; Masenko VP; Tereshchenko SN
Kardiologiia; 2018 Dec; 58(12S):27-41. PubMed ID: 30625106
[TBL] [Abstract][Full Text] [Related]
6. Clinical and classic echocardiographic features of patients with, and without, left ventricle reverse remodeling following the introduction of cardiac resynchronization therapy.
Wiliński J; Czarnecka D; Wojciechowska W; Kloch-Badełek M; Jastrzębski M; Bacior B; Sondej T; Kusak P; Przybyła A; Kawecka-Jaszcz K
Cardiol J; 2011; 18(2):157-64. PubMed ID: 21432822
[TBL] [Abstract][Full Text] [Related]
7. [Risk factors for pulmonary hypertension at the predialysis stage of chronic kidney disease].
Rudenko TE; Vasilyeva MP; Solomakhina NI; Kutyrina IM
Ter Arkh; 2016; 88(6):33-39. PubMed ID: 27296259
[TBL] [Abstract][Full Text] [Related]
8. Predictors of tachycardia-induced cardiomyopathy in patients with first-time decompensation of chro-nic heart failure with reduced left ventricular ejection fraction of nonischemic etiology and persistent atrial tachyarrhythmia.
Orlov OS; Asfour A; Bogdanova AA; Shchekochikhin DY; Akselrod AS; Nesterov AP; Andreev DA
Kardiologiia; 2022 Nov; 62(11):56-62. PubMed ID: 36521045
[TBL] [Abstract][Full Text] [Related]
9. Plasma tissue inhibitor of matrix metalloproteinase-1 a predictor of long-term mortality in patients treated with cardiac resynchronization therapy.
Trucco E; Tolosana JM; Castel MÁ; Batlle M; Borràs R; Sitges M; Guash E; Matas M; Arbelo E; Berruezo A; Brugada J; Mont L
Europace; 2016 Feb; 18(2):232-7. PubMed ID: 25883077
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the effects of cardiac resynchronization therapy on pathophysiological pathways of heart failure using surrogate biomarkers.
Sunman H; Özkan A; Yorgun H; Canpolat U; Karabulut E; Bayrak T; Kaya EB; Tokgözoğlu L; Özer N; Özkara A; Aytemir K; Oto A
Cardiol J; 2018; 25(1):42-51. PubMed ID: 28980281
[TBL] [Abstract][Full Text] [Related]
11. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
George J; Patal S; Wexler D; Roth A; Sheps D; Keren G
Am Heart J; 2005 Sep; 150(3):484-7. PubMed ID: 16169329
[TBL] [Abstract][Full Text] [Related]
12. Intrathoracic impedance changes reflect reverse left ventricular remodeling in response to cardiac resynchronization therapy in chronic heart failure patients.
Kaneshiro T; Suzuki H; Yamada S; Kamiyama Y; Saitoh S; Takeishi Y
Int Heart J; 2012; 53(4):249-52. PubMed ID: 22878804
[TBL] [Abstract][Full Text] [Related]
13. High sensitivity C-reactive protein predicts nonresponders and cardiac deaths in severe heart failure patients after CRT implantation.
Kamioka M; Suzuki H; Yamada S; Kamiyama Y; Saitoh S; Takeishi Y
Int Heart J; 2012; 53(5):306-12. PubMed ID: 23038092
[TBL] [Abstract][Full Text] [Related]
14. [Biomarkers of inflammation in patients with chronic heart failure and implanted devices for cardiac resynchronization therapy].
Kuznetsov VA; Soldatova AM; Enina TN; Shebeko PV; Rychkov AIu; Mel'nikov NN; Zateĭshchikov DA
Kardiologiia; 2012; 52(8):38-43. PubMed ID: 23098397
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and laboratory associations of liver fibrosis indexes in patients with decompensated Chronic Heart Failure II-IV Functional Classes].
Stolbova SK; Dragomiretskaya NA; Beliaev IG; Podzolkov VI
Kardiologiia; 2020 Jun; 60(5):920. PubMed ID: 32515709
[TBL] [Abstract][Full Text] [Related]
16. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
[TBL] [Abstract][Full Text] [Related]
17. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
[TBL] [Abstract][Full Text] [Related]
18. Effective prediction of response to cardiac resynchronization therapy using a novel program of gated myocardial perfusion single photon emission computed tomography.
Nakamura K; Takami M; Shimabukuro M; Maesato A; Chinen I; Ishigaki S; Higa S; Keida T; Masuzaki H
Europace; 2011 Dec; 13(12):1731-7. PubMed ID: 21873328
[TBL] [Abstract][Full Text] [Related]
19. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P
Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058
[TBL] [Abstract][Full Text] [Related]
20. Are changes in heart rate, observed during dobutamine stress echocardiography, associated with a response to cardiac resynchronisation therapy in patients with severe heart failure? Results of a multicentre ViaCRT study.
Gilewski W; Błażejewski J; Karasek D; Banach J; Wołowiec Ł; Płońska-Gościniak E; Kukulski T; Kasprzak J; Mizia-Stec K; Kowalik I; Gościniak P; Sinkiewicz W
Kardiol Pol; 2018; 76(3):611-617. PubMed ID: 29297189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
